An FDA-approved system (CELLSEARCH® Circulating Tumor Cell Kit–Menarini Silicon Biosystems Inc, Bologna, Italy) utilizes EpCAM and cytokeratins (CK8, CK18, and CK19) in CD45 negative circulating cells. The gene discussed is EPCAM; the disease is neoplasm.